Dermatology · Sewell, NJ
NPI
1740392075
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
570 Egg Harbor Rd Ste C1
Sewell, NJ, 08080
Phone (856) 256-8899
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
11,015 services
Medicare patients, 2024
747
Average age 76
Drug cost, 2024
$827K
1,483 prescriptions
Company payments, 2025
$4,253
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Booth H Durham was code J3245 (injection, tildrakizumab, 1 mg), 7,200 times for 17 patients. In total Booth H Durham billed 11,015 services in 63 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3245 Injection, tildrakizumab, 1 mg | Office | 7,200 | 17 | $107.60 | $775K |
| 99213 Office E&M - Established | Office | 1,056 | 682 | $72.12 | $76K |
| 17003 Destruction Skin Lesion | Office | 839 | 174 | $5.80 | $4,865 |
| 17000 Destruction Skin Lesion | Office | 365 | 256 | $44.16 | $16K |
| 11102 Skin Biopsy | Office | 207 | 188 | $80.16 | $17K |
| 99212 Office E&M - Established | Office | 110 | 95 | $49.51 | $5,446 |
| 96372 Injection Administration | Office | 105 | 25 | $12.04 | $1,264 |
| 17280 Destruction Skin Lesion | Office | 89 | 76 | $98.08 | $8,729 |
| 17261 Destruction Skin Lesion | Office | 85 | 69 | $111.74 | $9,498 |
| 17281 Destruction Skin Lesion | Office | 75 | 54 | $147.25 | $11K |
| 17270 Destruction Skin Lesion | Office | 63 | 46 | $115.76 | $7,293 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 52 | 25 | $0.75 | $38.77 |
| 17271 Destruction Skin Lesion | Office | 51 | 44 | $131.34 | $6,698 |
| 11103 Skin Biopsy | Office | 35 | 30 | $45.20 | $1,582 |
| 11900 Skin | Office | 35 | 22 | $43.26 | $1,514 |
By year: 2022 $826K for 9,898 services; 2023 $944K for 10,563 services; 2024 $1.0M for 11,015 services.
Medicare prescription drug claims, 2024
In 2024, the drug Booth H Durham prescribed most often to Medicare patients was Mupirocin, with 207 prescriptions and refills. In total Booth H Durham wrote 1,483 Medicare prescriptions that cost $827K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 207 | 215 | 147 | $1,311 |
| Triamcinolone Acetonide Generic | 185 | 213 | 126 | $2,040 |
| Ketoconazole Generic | 109 | 170 | 56 | $3,172 |
| Minoxidil Generic | 104 | 303 | 32 | $1,067 |
| Valacyclovir Valacyclovir Hcl | 54 | 86 | 26 | $1,108 |
| Doxycycline Monohydrate Generic | 50 | 112 | 22 | $1,676 |
| Clobetasol Propionate Generic | 43 | 63 | 21 | $2,564 |
| Hydrocortisone Generic | 43 | 59 | 29 | $332 |
| Fluorouracil Generic | 42 | 44 | 37 | $2,764 |
| Betamethasone Dipropionate Generic | 37 | 38 | 29 | $1,430 |
| Metronidazole Generic | 33 | 37 | 31 | $3,086 |
| Mometasone Furoate Generic | 28 | 43 | 20 | $609 |
| Fluocinonide Generic | 28 | 38 | 17 | $833 |
| Spironolactone Generic | 27 | 75 | Under 11 | $535 |
| Methotrexate Methotrexate Sodium | 26 | 49 | Under 11 | $365 |
Brand drugs: 184 claims; generic drugs: 1,299 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Booth H Durham $4,253 ($4,253 in general payments such as food, travel and fees) from 23 companies. The largest payer was UCB, Inc. with $639.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 24 | $639 |
| Abbvie Inc. ABBV | 22 | $601 |
| Janssen Biotech, Inc. JNJ | 10 | $597 |
| LEO Pharma Inc. | 41 | $458 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $343 |
| Incyte Corporation INCY | 9 | $272 |
| Lilly USA, LLC LLY | 6 | $206 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 7 | $205 |
| Merz North America, Inc. | 2 | $139 |
| Amgen Inc. AMGN | 7 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.